CLL Monthly Minutes
The use of telemedicine has shown rapid growth over the course of the pandemic, with some experts suggesting that it is here to stay. Read More ›
Can a digital coach improve health outcomes in patients with blood cancers? An ongoing clinical trial should provide insights. Read More ›
Three patients with chronic lymphocytic leukemia were found to have progression to B-ALL after treatment with lenalidomide causing early termination of a clinical study. Read More ›
It is recommended that most patients with CLL receive the COVID-19 vaccine, although each patient should still talk with their healthcare team first. Read More ›
A new laboratory-based scoring system may allow physicians to better predict which patients with early-stage CLL are most likely to require early treatment. Read More ›
Patients with CLL may be at increased risk for developing severe COVID-19. Experts have provided insights on how to protect them while still delivering optimal care. Read More ›
Updated National Comprehensive Cancer Network (NCCN) guidelines now recommend zanubrutinib as alternative first- and second-line therapy for some patients. Read More ›
Cannabis compounds such as cannabidiol have shown cancer-fighting activity in the lab. What should patients know? Read More ›
A new model of the symptoms and impacts faced by patients may lead to better clinical tools for understanding the patient experience. Read More ›
Patients who are in a period of active observation should feel comfortable sharing anything that seems abnormal with their healthcare provider. Read More ›